RG

Rita Gupta

Active Director Director DIN 09800817
DIN 09800817 First appointment Nov 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Rita Gupta

Data last updated:

Rita Gupta is a Director at Medecale Pharma Private Limited (since 2022). The company operates in Chemicals. Medecale Pharma Private Limited reported revenue of ₹79.7 Lakh (FY 2025).

DIN 09800817
Primary Designation Director
Industry Chemicals
First Appointment 23 Nov 2022
Oldest Company Age 3 yrs
Largest company Medecale Pharma Private Limited · ₹79.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medecale Pharma Private Limited U24290UP2022PTC173856
Director23 Nov 20222022₹79.7 Lakh (FY 2025)Active

Board colleagues of Rita Gupta

Directorship timeline

Open interactive timeline →
Medecale Pharma Private Limited
Premium access

Shareholding and investment profile for Rita Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rita Gupta

Rita Gupta currently holds 1 directorship: Medecale Pharma Private Limited (Director, since 23 Nov 2022, revenue ₹79.7 Lakh (FY 2025)).

Rita Gupta was first appointed on 23 Nov 2022 as Director at Medecale Pharma Private Limited.

The current boards of Rita Gupta's companies include Anjali Gupta (Medecale Pharma Private Limited), Nevedita Gupta (Medecale Pharma Private Limited), Radhe Krishnan Gupta (Medecale Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available